Filing Details
- Accession Number:
- 0001209191-23-048436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-06 17:01:21
- Reporting Period:
- 2023-09-05
- Accepted Time:
- 2023-09-06 17:01:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1804591 | 23Andme Holding Co. | ME | Pharmaceutical Preparations (2834) | 871240344 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1988459 | G William Richards | C/O 23Andmeholding Co. 349 Oyster Point Blvd South San Francisco CA 94080 | Head Of Therapeutics Discovery | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-09-05 | 2,538 | $1.08 | 211,041 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 2,538 shares of Class A common stock of the issuer that were acquired under the 23andMe Holding Co. Employee Stock Purchase Plan on August 31, 2023.
Billionaire Hedge Funds
